Daniel Moreno
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Developmental Neuroscience top 10%
Papers in
-
- Trace Elements in Health 6
- Co-authors
- Í. Navarro-Blasco (5 shared papers)Marı́a J. Garrido (4 shared papers)Gloria González‐Aseguinolaza (6 shared papers)Sara Zalba (3 shared papers)Oihana Murillo (5 shared papers)Rubén Hernández-Alcoceba (5 shared papers)Cristina Gázquez (5 shared papers)Conchita Tros de Ilarduya (2 shared papers)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Microchemical Journal (1 paper)Journal of Hepatology (1 paper)Hepatology (1 paper)PLoS ONE (1 paper)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Daniel Moreno
18 papers receiving 526 citations
Peers
Comparison fields: 5 of 81
- Pharmaceutical Science 61
- Developmental Neuroscience 35
- Nutrition and Dietetics 121
- Biomaterials 86
- Health, Toxicology and Mutagenesis 76
Countries citing papers authored by Daniel Moreno
This map shows the geographic impact of Daniel Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Moreno more than expected).
Fields of papers citing papers by Daniel Moreno
This network shows the impact of papers produced by Daniel Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Moreno. The network helps show where Daniel Moreno may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Moreno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 124 | |
| 2 | 2015 | 97 | |
| 3 | 2009 | 66 | |
| 4 | 2019 | 40 | |
| 5 | 1997 | 38 | |
| 6 | 1997 | 32 | |
| 7 | 2007 | 31 | |
| 8 | 2022 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2024 | 17 | |
| 11 | 2015 | 14 | |
| 12 | 2013 | 12 | |
| 13 | 2009 | 10 | |
| 14 | 2010 | 5 | |
| 15 | 2007 | 4 | |
| 16 | 2013 | 4 | |
| 17 | 2016 | 3 | |
| 18 | [Wilson's disease. A retrospective analysis of 12 cases]. | 1992 | 3 |
| 19 | 2016 | 0 | |
| 20 | 2025 | 0 |
About Daniel Moreno
Daniel Moreno is a scholar working on Nutrition and Dietetics, Molecular Biology, Oncology, Biomaterials and Hepatology, having authored 20 papers that have together received 536 indexed citations. Recurring topics across this work include Trace Elements in Health (6 papers), Liver physiology and pathology (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Organ Transplantation Techniques and Outcomes (3 papers), Metabolism and Genetic Disorders (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (61 citations), Developmental Neuroscience (35 citations), Nutrition and Dietetics (121 citations), Biomaterials (86 citations) and Health, Toxicology and Mutagenesis (76 citations). Daniel Moreno has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Í. Navarro-Blasco, Marı́a J. Garrido, Gloria González‐Aseguinolaza, Sara Zalba, Oihana Murillo, Rubén Hernández-Alcoceba, Cristina Gázquez, Conchita Tros de Ilarduya, Laura Montani and Joanne Gerber. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Microchemical Journal, Journal of Hepatology, Hepatology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.